190 related articles for article (PubMed ID: 24462006)
1. Calculation of operating expenses for conventional transarterial chemoembolization in an academic medical center: a step toward defining the value of transarterial chemoembolization.
Beheshti MV; Meek J
J Vasc Interv Radiol; 2014 Apr; 25(4):567-74. PubMed ID: 24462006
[TBL] [Abstract][Full Text] [Related]
2. Cost Accounting as a Tool for Increasing Cost Transparency in Selective Hepatic Transarterial Chemoembolization.
Ahmed O; Patel M; Ward T; Sze DY; Telischak K; Kothary N; Hofmann LV
J Vasc Interv Radiol; 2015 Dec; 26(12):1820-6.e1. PubMed ID: 26521766
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
Rostambeigi N; Dekarske AS; Austin EE; Golzarian J; Cressman EN
J Vasc Interv Radiol; 2014 Jul; 25(7):1075-84. PubMed ID: 24861664
[TBL] [Abstract][Full Text] [Related]
4. The importance of the value proposition for IR.
Ray CE
J Vasc Interv Radiol; 2014 Apr; 25(4):575. PubMed ID: 24674215
[No Abstract] [Full Text] [Related]
5. Interventional radiologic treatment of hepatocellular carcinoma-a cost analysis from the payer perspective.
Ray CE; Battaglia C; Libby AM; Prochazka A; Xu S; Funaki B
J Vasc Interv Radiol; 2012 Mar; 23(3):306-14. PubMed ID: 22277271
[TBL] [Abstract][Full Text] [Related]
6. A Single-Center Retrospective Comparison of Doxorubicin-Loaded HepaSphere Transarterial Chemoembolization with Conventional Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma.
Kucukay F; Badem S; Karan A; Ozdemir M; Okten RS; Ozbulbul NI; Kucukay MB; Unlu I; Bostanci EB; Akdogan M
J Vasc Interv Radiol; 2015 Nov; 26(11):1622-9. PubMed ID: 26321015
[TBL] [Abstract][Full Text] [Related]
7. Operating expenses for the diagnosis and treatment of peripheral vascular disease in an academic interventional radiology department: cost calculations according to a microeconomic method.
Janne d'Othée B; Langdon DR; Bell GK; Bettmann MA
J Vasc Interv Radiol; 2006 Jan; 17(1):85-94. PubMed ID: 16415137
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Drug-Eluting Embolics versus Conventional Transarterial Chemoembolization for the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
Wu X; Chapiro J; Malhotra A; Kothary N
J Vasc Interv Radiol; 2021 Jan; 32(1):2-12.e1. PubMed ID: 33160827
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
Prajapati HJ; Dhanasekaran R; El-Rayes BF; Kauh JS; Maithel SK; Chen Z; Kim HS
J Vasc Interv Radiol; 2013 Mar; 24(3):307-15. PubMed ID: 23375519
[TBL] [Abstract][Full Text] [Related]
10. Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinoma.
Vadot L; Boulin M; Guiu B; Aho LS; Vourc'h M; Musat A; Hillon P; Lepage C; Guignard MH; Fagnoni P
J Clin Pharm Ther; 2015 Feb; 40(1):83-90. PubMed ID: 25413186
[TBL] [Abstract][Full Text] [Related]
11. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
[TBL] [Abstract][Full Text] [Related]
12. Conventional Ethiodized Oil Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma: Contemporary Single-Center Review of Clinical Outcomes.
Casadaban LC; Minocha J; Bui JT; Knuttinen MG; Ray CE; Gaba RC
AJR Am J Roentgenol; 2016 Mar; 206(3):645-54. PubMed ID: 26901023
[TBL] [Abstract][Full Text] [Related]
13. From good to good deal: value-focused research.
Duszak R
J Vasc Interv Radiol; 2012 Mar; 23(3):315-6. PubMed ID: 22365290
[No Abstract] [Full Text] [Related]
14. Outpatient Transarterial Chemoembolization of Hepatocellular Carcinoma: Review of a Same-Day Discharge Strategy.
Fritsche MR; Watchmaker JM; Lipnik AJ; Baker JC; Geevarghese S; Banovac F; Omary RA; Brown DB
J Vasc Interv Radiol; 2018 Apr; 29(4):550-555. PubMed ID: 29478795
[TBL] [Abstract][Full Text] [Related]
15. Arterial portography during transarterial chemoembolization: still a necessity in the age of contrast-enhanced cross-sectional imaging?
Hui TC; Pua U
J Vasc Interv Radiol; 2014 Jan; 25(1):41-6. PubMed ID: 24290098
[TBL] [Abstract][Full Text] [Related]
16. Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan.
Nguang SH; Wu CK; Liang CM; Tai WC; Yang SC; Ku MK; Yuan LT; Wang JW; Tseng KL; Hung TH; Hsu PI; Wu DC; Chuah SK; Hsu CN
Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30486324
[TBL] [Abstract][Full Text] [Related]
17. Noncontrast chest computed tomography immediately after transarterial chemoembolization in patients with hepatocellular carcinoma: clinical benefits and effect of radiation reduction on image quality in low-dose scanning.
Choi JI; Kim HB; Kim MJ; Lee JS; Koh YW; An SB; Ko HK; Park JW
Eur J Radiol; 2011 Nov; 80(2):e188-94. PubMed ID: 21708441
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
[TBL] [Abstract][Full Text] [Related]
19. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization.
Yang L; Zhang XM; Zhou XP; Tang W; Guan YS; Zhai ZH; Dong GL
J Vasc Interv Radiol; 2010 Dec; 21(12):1841-6. PubMed ID: 20980165
[TBL] [Abstract][Full Text] [Related]
20. Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization.
Prajapati HJ; Rafi S; El-Rayes BF; Kauh JS; Kooby DA; Kim HS
J Vasc Interv Radiol; 2012 Oct; 23(10):1286-93.e1. PubMed ID: 22999748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
